Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?

NCT00867971 is registered in ClinicalTrials.gov with Assaf-Harofeh Medical Center as lead sponsor.

NCT NCT00867971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00867971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Recombinant Growth Hormone Therapy Associated With Increased Intraoccular Pressure?
Lead sponsor
Assaf-Harofeh Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2009
Completion date
October 31, 2010
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, growth hormone treatment